Feasibility of Real-World Assessment of Patient-Reported Outcomes in Acute Myeloid Leukemia by Cytogenetic Risk and Treatment Status
This study demonstrates the feasibility of gathering PROs with real-world data among a cohort of patients with AML using a remote symptom monitoring platform, across baseline prognostic and therapeutic factors.
CareviveDecember 12, 2022